Atria Investments’s Evotec EVO Stock Holding History

Atria Investments’s Portfolio EVO Stock Details EVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13,286	Closed	-$33.2K	–	2158
2026 Q1	$33.2K	Buy	+13,286	New	+$42.8K	﹤0.01%	2026

Other funds holding EVO

DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

Fore Capital New York $338M AUM 10.07% 1-Year Est. Return

Atria Investments's EVO Position: Q2 2026 in Review

Atria Investments sold out of Evotec (EVO) in Q2 2026, closing a stake of 13,286 shares — an estimated $33.2K sold.

Atria Investments first reported a position in EVO in Q1 2026 and held it in 1 quarter. The position peaked at $33.2K in Q1 2026. 34 funds tracked by Wall St. Rank hold EVO as of Q2 2026.

Atria Investments reported no remaining Evotec position as of Q2 2026 after selling out during the quarter.
Atria Investments sold 13,286 Evotec shares in Q2 2026, an estimated $33.2K.
Atria Investments first reported a position in Evotec in Q1 2026 and held it in 1 quarter.
Atria Investments's Evotec position peaked at $33.2K in Q1 2026.
34 funds tracked by Wall St. Rank held Evotec as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.